Pages that link to "Q24622136"

The following pages link to Biological markers of amyloid beta-related mechanisms in Alzheimer's disease (Q24622136):

Displaying 50 items.

• Meta-Review of CSF Core Biomarkers in Alzheimer's Disease: The State-of-the-Art after the New Revised Diagnostic Criteria (Q26864063) (← links)
• The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception (Q27006831) (← links)
• Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials (Q27310276) (← links)
• Alzheimer's Disease and Non-Demented High Pathology Control Nonagenarians: Comparing and Contrasting the Biochemistry of Cognitively Successful Aging (Q28477836) (← links)
• The Clinical Value of Large Neuroimaging Data Sets in Alzheimer's Disease (Q28709465) (← links)
• The Alzheimer's disease neuroimaging initiative: progress report and future plans (Q28749585) (← links)
• A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling (Q30235315) (← links)
• Mismatch negativity (MMN) amplitude as a biomarker of sensory memory deficit in amnestic mild cognitive impairment. (Q30446194) (← links)
• Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease (Q30845482) (← links)
• 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (Q30971403) (← links)
• Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions (Q30998279) (← links)
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. (Q31063014) (← links)
• Total and phosphorylated tau protein as biological markers of Alzheimer's disease (Q33624674) (← links)
• Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects (Q33842486) (← links)
• The future of blood-based biomarkers for Alzheimer's disease (Q34026317) (← links)
• The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. (Q34065449) (← links)
• Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry (Q34157882) (← links)
• Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification (Q34183016) (← links)
• Relationship of dementia screening tests with biomarkers of Alzheimer's disease (Q34247824) (← links)
• A common BACE1 polymorphism is a risk factor for sporadic Creutzfeldt-Jakob disease (Q34405864) (← links)
• Dementia screening, biomarkers and protein misfolding: Implications for public health and diagnosis (Q34570041) (← links)
• Identification and quantification of amyloid beta-related peptides in human plasma using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (Q35118876) (← links)
• High Throughput ELISAs to Measure a Unique Glycan on Transferrin in Cerebrospinal Fluid: A Possible Extension toward Alzheimer's Disease Biomarker Development (Q35178436) (← links)
• Emerging antibody products and Nicotiana manufacturing (Q35194874) (← links)
• Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. (Q35218413) (← links)
• Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease (Q35284971) (← links)
• The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease (Q35327219) (← links)
• Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. (Q35610552) (← links)
• Mass spectral analysis of urine proteomic profiles of dairy cows suffering from clinical ketosis (Q35641886) (← links)
• Magnetization-prepared rapid acquisition with gradient echo magnetic resonance imaging signal and texture features for the prediction of mild cognitive impairment to Alzheimer's disease progression (Q35775390) (← links)
• Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease (Q35991723) (← links)
• The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations (Q36165011) (← links)
• Alzheimer disease and platelets: how's that relevant (Q36535484) (← links)
• Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies (Q36574825) (← links)
• Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes (Q36687762) (← links)
• Biomarkers of Alzheimer's disease among Mexican Americans. (Q36716970) (← links)
• Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. (Q36740479) (← links)
• Neuropathological approaches to cerebral aging and neuroplasticity (Q36755159) (← links)
• Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers (Q37410700) (← links)
• A cellular model of amyloid precursor protein processing and amyloid-β peptide production (Q37596735) (← links)
• PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease (Q37718557) (← links)
• Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer’s disease: a tribute to Moussa Youdim (Q37848245) (← links)
• Behavioural and cellular effects of exogenous amyloid-β peptides in rodents (Q37925170) (← links)
• Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease (Q37942341) (← links)
• CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease (Q37953330) (← links)
• Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease (Q38002654) (← links)
• The development of effective biomarkers for Alzheimer's disease: a review (Q38016800) (← links)
• Plasma biomarkers for Alzheimer's disease: much needed but tough to find (Q38037157) (← links)
• DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, (Q38243166) (← links)
• Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies (Q38344088) (← links)